Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain

ClinicalTrials.gov ID: NCT02362672

Public ClinicalTrials.gov record NCT02362672. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 10:57 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine whether a new opioid molecule, NKTR-181, is effective for the relief of moderate to severe chronic low back pain as compared to a placebo.

Study identification

NCT ID
NCT02362672
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Nektar Therapeutics
Industry
Enrollment
1,189 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 11, 2015 (Actual)
Primary completion
Dec 2016 (Actual)
Completion
Feb 2017 (Actual)
Last update posted
Sep 16, 2020

2015 – 2017

United States locations

U.S. sites
54
U.S. states
27
U.S. cities
51
Facility City State ZIP Site status
Investigator Site - Saraland Saraland Alabama 36571 —
Investigator Site - Phoenix Phoenix Arizona 85023 —
Investigator Site - Tempe Tempe Arizona 85283 —
Investigator Site - Little Rock Little Rock Arkansas 72211 —
Investigator Site - Stamford Stamford Connecticut 06905 —
Investigator Site - Clearwater Clearwater Florida 33765 —
Investigator Site - Fort Lauderdale Fort Lauderdale Florida 33312 —
Investigator Site - Jacksonville Jacksonville Florida 32257 —
Investigator Site - Orlando Orlando Florida 32806 —
Investigator Site - Ormond Beach Ormond Beach Florida 32174 —
Investigator Site - Plantation Plantation Florida 33324 —
Investigator Site - Tampa Tampa Florida 33603 —
Investigator Site - West Palm Beach West Palm Beach Florida 33409 —
Investigator Site - Atlanta Atlanta Georgia 30338 —
Investigator Site - Blue Ridge Blue Ridge Georgia 30513 —
Investigator Site - Marietta Marietta Georgia 30060 —
Investigator Site - Norcross Norcross Georgia 30092 —
Investigator Site - Gurnee Gurnee Illinois 60031 —
Investigator Site - West Des Moines West Des Moines Iowa 50265 —
Investigator Site - Wichita Wichita Kansas 67207 —
Investigator Site - Louisville Louisville Kentucky 40213 —
Investigator Site - Bossier Bossier City Louisiana 71111 —
Investigator Site - New Orleans New Orleans Louisiana 70115 —
Investigator Site - Shreveport Shreveport Louisiana 71105 —
Investigator Site - Bay City Bay City Michigan 48706 —
Investigator Site - Pinconning Pinconning Michigan 48706 —
Investigator Site - Biloxi Biloxi Mississippi 39531 —
Investigator Site - Saint Louis 1 St Louis Missouri 63141 —
Investigator Site - Saint Louis 2 St Louis Missouri 63141 —
Investigator Site - Omaha Omaha Nebraska 68134 —
Investigator Site - Las Vegas 2 Las Vegas Nevada 89102 —
Investigator Site - Las Vegas 1 Las Vegas Nevada 89119 —
Investigator Site - Rochester Rochester New York 14642 —
Investigator Site - Williamsville Williamsville New York 14221 —
Investigator Site - Greensboro Greensboro North Carolina 27410 —
Investigator Site - Winston Salem Winston-Salem North Carolina 27103 —
Investigator Site - Fargo Fargo North Dakota 58104 —
Investigator Site - Beavercreek Beavercreek Ohio 45432 —
Investigator Site - Cincinnati 1 Cincinnati Ohio 45219 —
Investigator Site - Cincinnati 2 Cincinnati Ohio 45246 —
Investigator Site - Columbus Columbus Ohio 43235 —
Investigator Site - Duncansville Duncansville Pennsylvania 16635 —
Investigator Site - Jenkintown Jenkintown Pennsylvania 19046 —
Investigator Site - Rapid City Rapid City South Dakota 57702 —
Investigator Site - Memphis Memphis Tennessee 38119 —
Investigator Site - Arlington Arlington Texas 76012 —
Investigator Site - Austin Austin Texas 78731 —
Investigator Site - Killeen Killeen Texas 76543 —
Investigator Site - San Antonio San Antonio Texas 78229 —
Investigator Site - Salt Lake City Salt Lake City Utah 84124 —
Investigator Site - West Jordan West Jordan Utah 84088 —
Investigator Site - Midlothian Midlothian Virginia 23114 —
Investigator Site - Norfolk Norfolk Virginia 23507 —
Investigator Site - Kenosha Kenosha Wisconsin 53142 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02362672, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 16, 2020 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02362672 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →